|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
ERSTE STOCK BIOTEC
AT0000746755
EUR / Acc. / Retail
|
17.04.2000
26,4 Jahre
|
298,97 |
+14,35% |
+40,16% |
+49,49% |
+35,17% |
|
UBS (Lux) Equity Fund - Biotech (USD)
LU0069152568
USD / Acc. / Retail
|
15.10.1996
29,9 Jahre
|
469,89 |
+25,60% |
+54,01% |
+52,58% |
+29,70% |
|
PPF ("PMG Partners Funds") - Helix Biotechnology Fund
LU1230343250
USD / Acc. / Retail
|
21.10.2015
10,9 Jahre
|
37,35 |
+30,36% |
+71,16% |
+60,19% |
+2,37% |
|
iShares Nasdaq US Biotechnology UCITS ETF
IE00BYXG2H39
USD / Acc. / Retail
|
19.10.2017
8,9 Jahre
|
1.097,26 |
+26,26% |
+53,52% |
+63,31% |
+37,82% |
|
MEDICAL BioHealth
LU0119891520
EUR / Acc. / Retail
|
30.10.2000
25,9 Jahre
|
|
+13,96% |
+44,59% |
+63,49% |
+54,43% |
|
Invesco NASDAQ Biotech UCITS ETF
IE00BQ70R696
USD / Acc. / Retail
|
06.11.2014
11,9 Jahre
|
429,77 |
+26,39% |
+53,76% |
+63,51% |
+38,04% |
|
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund
LU1540961759
USD / Acc. / Retail
|
30.12.2011
14,7 Jahre
|
16,41 |
+13,56% |
+41,06% |
+63,63% |
+32,10% |
|
Aescap Life Sciences
NL0012343958
EUR / Acc. / Retail
|
29.03.2016
10,5 Jahre
|
137,38 |
+7,62% |
+53,36% |
+66,76% |
+22,11% |
|
Candriam Equities L Biotechnology
LU0108459040
USD / Acc. / Retail
|
06.04.2000
26,5 Jahre
|
1.813,67 |
+23,45% |
+57,33% |
+75,28% |
+74,75% |
|
RIM Global Bioscience
LU0120651160
EUR / Dist. / Retail
|
13.02.2001
25,6 Jahre
|
|
+15,75% |
+51,15% |
+79,88% |
+66,90% |